AI Stock Analysis: Is TDOC a Buy?

December 27, 4:41 am

Teladoc Health, Inc. is a telemedicine and virtual healthcare company that uses telephone and videoconferencing software to provide on-demand remote medical care via mobile devices, the internet, video and phone, 24/7. Their services include telehealth, medical opinions, AI and analytics, telehealth devices, and licensable platform services. Amidst the evolving healthcare landscape, Teladoc Health aims to innovate beyond traditional in-person consultations, emphasizing the increasing importance of accessible, convenient medical care.

Price & AI Score for TDOC.

Fundamental Analysis

Revenue: For the last quarter, Teladoc Health reported a revenue of $641 million. This represents a slight decrease of 0.30% compared to the previous quarter and a 2.15% decrease compared to the same quarter last year. These declines may be a cause for concern, suggesting a potential stagnation or contraction in the company's earnings.

Net Income: The net income for the last quarter was $33 million, an impressive increase of 96.03% from the previous quarter and 41.70% from the same quarter last year. This substantial growth indicates that despite a slight decrease in revenue, Teladoc Health is improving its profitability.

EBITDA: The EBITDA for the last quarter was $63 million, showing an increase of 108.58% from the previous quarter and 55.32% from the same quarter last year. This growth in operating earnings is a positive sign, reflecting the company’s efficiency in managing its operating expenses.

Insider Activity: The recent sale of shares by company insiders could potentially be considered a bearish signal, indicating that internal stakeholders might anticipate a decline in the stock's performance.

Technical Analysis

Stock Price: The current stock price is $9.53, representing a decrease of 16.62% from a month ago and a significant drop of 56.88% from a year ago. This considerable decline may indicate potential weaknesses or market concerns in the short and long term.

Simple Moving Average (SMA): The current 10-day SMA is $9.33, slightly lower than the previous SMA10 of $9.39, suggesting a potential downward trend in price movement.

Relative Strength Index (RSI): At 32.2, the RSI indicates a neutral condition. However, since it is near the lower threshold of the RSI range, it may also indicate that the stock is nearing an oversold condition.

Alternative Data Analysis

Job Postings and Employee Sentiment: Teladoc Health currently has 86 open positions, a 6% increase over the last few months, suggesting a potential for growth and expansion. However, employee sentiment is relatively low, with only 40% having a positive outlook on the business, which could pose a concern for company culture and future performance.

Customer Acquisition: The company's website has seen a 19% increase in visitors recently, totaling 990,000. Additionally, the daily app downloads number 2,400, an 11% increase over the last couple of months. These bullish trends indicate a growing customer base.

Customer Engagement: On social platforms, Teladoc Health has 12,000 followers on Instagram (up 6%) and 18,000 on Twitter (down 1%). While Instagram interest is growing, the slight decline on Twitter indicates mixed engagement outcomes.

AI Score: The AltIndex AI score for Teladoc Health is 63, which translates to a buy signal based on fundamental, technical, and alternative data analysis.

Conclusion and Recommendation

While Teladoc Health faces some challenges, such as declining revenue and significant stock price drops over the short and long term, its net income and EBITDA growth signals improving profitability. Based on the technical analysis, there may be short-term downward pressure on the stock price. However, alternative data shows positive trends in job postings, web traffic, and app downloads, suggesting potential future growth.

Considering the fundamentals, technical indicators, and alternative data, the overall recommendation is to closely monitor Teladoc Health for potential buying opportunities if the company's growth strategies continue to yield positive results and profitability sustains.

Disclaimer: This article, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current. Visit TDOC AI Stock Analysis for a more up-to-date analysis.

Get More Insights

Sign up and get access to a personalized dashboard, deeper insights, AI stock picks, stock alerts, weekly newsletter and much more.